Key informationMain study endpoints- Change from baseline in the relief of nasal congestion - Common cold symptoms-...
![[CASE STUDY] Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults](https://www.biofortis.fr/wp-content/uploads/2023/06/Featured-image-website_-case-studies-1-940x675.png)
Case studies_Clinical
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults](https://www.biofortis.fr/wp-content/uploads/2023/05/14-940x675.png)
[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults
Key informationMain study endpoints- Number of bowel movements - Bowel habits - Stool consistency - Severity of...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia](https://www.biofortis.fr/wp-content/uploads/2023/05/13-940x675.png)
[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia
Key informationMain study endpoints- Glycemia - Lipid and glucose profile/homeostasia - DEXAPopulation636 prediabetes...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia](https://www.biofortis.fr/wp-content/uploads/2023/05/13-400x250.png)
[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia
Key informationMain study endpoints- Glycemia - Lipid and glucose profile/homeostasia - DEXAPopulation636 prediabetes patientsTested productPlant extractsInvestigations53 sites in 7 countries : France, Germany, Italy, Bulgaria, Hungary, Poland and RomaniaKey...
![[CASE STUDY] Safety and suitability of an infant formula in healthy term infants](https://www.biofortis.fr/wp-content/uploads/2023/05/12-400x250.png)
[CASE STUDY] Safety and suitability of an infant formula in healthy term infants
Key informationMain study endpointsSafety: growth parameters, adverse eventsPopulation360 babiesTested productInfant formula manufactured from extensively hydrolysed proteinInvestigations21 sites around the worldkey challenge- 360 infants included in less than 2...
![[CASE STUDY] Evaluation of the efficacy of a symbiotic infant formula on the incidence of gastroenterological infectious diseases during the first year of life](https://www.biofortis.fr/wp-content/uploads/2023/04/11-400x250.png)
[CASE STUDY] Evaluation of the efficacy of a symbiotic infant formula on the incidence of gastroenterological infectious diseases during the first year of life
Key informationMain study endpoints- Reduction in the incidence rate of infectious diarrhea - Modulation of intestinal microbiota - Impact on immune systemPopulation540 babiesTested productInfant milk enriched with pre and probioticsInvestigations42 sites (general...